Does the global economy need to start dismantling 'global white privilege'? The Black Lives matter protest movement has focussed lots of attention on racial attitudes in rich western countries. How easy is it for instance, for people of black or Asian heritage to get on the ladder to business success in those countries? But is the economics of what's now called 'white privilege' a global problem too? Ed Butler speaks to Chandran Nair, the founder and Chief Executive Officer of The Global Institute for Tomorrow, an independent think-tank in Hong Kong and the author of ‘Dismantling Global White Privilege: Equity for a Post-Western World’. And also to Lucinda Platt, from the London School of Economics, who has recently written a report for the IFS on the degree of social and economic mobility being achieved among the UK's minority racial and ethnic groups.
Bitte melde dich an oder registriere dich, um fortfahren zu können.
Folgen von Business Daily
2000 Folgen
-
Folge vom 11.01.2022White privilege
-
Folge vom 10.01.2022Healing the mindPsychedelic therapy could provide a major breakthrough in the treatment of mental health disorders like depression, and now it's caught the attention of start-ups and venture capitalists.Laurence Knight hears from one man whose life was transformed by a single dose of the drug psilocybin - the psychoactive ingredient in magic mushrooms - after he volunteered for a research project exploring whether it could cure depression. He also visits the research team at King's College London, who have just wrapped up the latest trials of the drug. The trials are being sponsored by the healthcare start-up Compass Pathways, and its founder and chief executive George Goldsmith explains why he hopes to use them to bring this therapy to the general public. Plus Amanda Eilian of venture capitalists Able Partners describes how quickly attitudes in the investor community are changing.(Picture credit: Getty Images)
-
Folge vom 08.01.2022Business Weekly: 08/01/2022On this edition of Business Weekly, we’re looking at the tech giant Apple. Its value tipped over the $3 trillion mark on the New York stock Exchange at the start of the year. We hear from Dan Ives of Wedbush Securities on possible further avenues of growth for the company. We’ll take you to the United States to hear from different communities all hoping to benefit from President Biden’s $1.2 trillion infrastructure plan. We focus on projects designed to improve the quality of drinking water, and public transport. The BBC’s Will Bain covers examples from Alaska, Michigan and California. Plus, we remember the work of the world renowned Kenyan paleoanthropologist Richard Leakey, who died at the start of the year. We hear from Dr Paula Kahumbu who knew him from childhood, and now runs one of the organisations he founded. Business Weekly is presented by Sasha Twining and produced by Clare Williamson.
-
Folge vom 07.01.2022Starting a company to fight rare diseaseMapping the human genome led to big advances in diagnosing rare disease. But diagnosis is only the first step in dealing with an illness. So what do you do if your child is found to have a condition that has no treatment? We hear from Michelle Teng, a mother who co-founded a biotech firm called SynaptixBio, that is looking to find the world’s first treatment for a rare neurodegenerative disease. Also in the programme, the Chief Medical Officer at Genomics England, Dr Richard Scott, tells us his hopes for the future of genomics medicine. And Dr Segun Fatumo of the London School of Hygiene and Tropical Medicine, explains why Africa is so important when it comes to genetic research. Presented by Vivienne Nunis and produced by Sarah Treanor. Image: Scientists look at a DNA model. Credit: Getty Images.